Citicoline

Category
nootropic
Routes
Oral (PO)
Half-Life (t½)
PO: 56h
Formula
C14H26N4O11P2
Molecular Weight
488.32 g/mol
PubChem CID
13804
Aliases
cdp-choline

Pharmacological Mechanism

Cytidine and choline donor; supports phosphatidylcholine synthesis.

Half-Life & Elimination Curve (PO: 56h)

100%50%25%12.5%0%0h0×t½56h1×t½4.7d2×t½7d3×t½9.3d4×t½11.7d5×t½0×t½ (0h): 100% remaining (~17.9 mg/L)1×t½ (56h): 50% remaining (~8.95 mg/L)2×t½ (4.7d): 25% remaining (~4.47 mg/L)3×t½ (7d): 12.5% remaining (~2.24 mg/L)4×t½ (9.3d): 6.3% remaining (~1.12 mg/L)5×t½ (11.7d): 3.1% remaining (~0.559 mg/L)
Plasma (PO)t½ Decay (56h)Effect Site (ke0)
  • 0×t½0h100% (17.9 mg/L)
  • 1×t½56h50% (8.95 mg/L)
  • 2×t½4.7d25% (4.47 mg/L)
  • 3×t½7d12.5% (2.24 mg/L)
  • 4×t½9.3d6.3% (1.12 mg/L)
  • 5×t½11.7d3.1% (0.559 mg/L)
Elimination t½56h (PO)
Rate Constant (ke)0.0124 h⁻¹
Time to Peak (Tmax)8.97h
Est. Peak (Cmax)17.9 mg/L
Clearance (CL)0.309 L/h
97% Washout (5×t½)11.7d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Notes

Hydrolyzed in gut to cytidine + choline before absorption.

Chemical Structure & Identifiers

References